ROR1 x CD3 DART

N/A

Report date: 2026/03/19 17:22:45

Base Information

Drug NameROR1 x CD3 DART

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 antagonistsCD3 T-cell engagersWnt signalling pathway modulators

TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1T cell surface glycoprotein CD3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMacrogenics Inc

China Registration ClassN/A

Develop Information

Active CompaniesMacrogenics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A